Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial

Mike J. Crawford, Helen Killaspy, Diane Waller, Thomas R.E. Barnes, Barbara Barrett, Sarah Byford, Katie Clayton, John Dinsmore, Siobhan Floyd, Angela Hoadley, Tony Johnson, Eleftheria Kalaitzaki, Michael King, Baptiste Leurent, Anna Maratos, Francis A. O'Neill, David P. Osborn, Sue Patterson, Tony Soteriou, Peter Tyrer

Research output: Contribution to journalArticle

Abstract

Abstract: Objectives: To evaluate he clinical effectiveness of group art therapy for people with schizophrenia and to test whether any benefits exceed those of an active control treatment. Design: Three arm, rater blinded, pragmatic, randomised controlled trial. Setting: Secondary care services across 15 sites in the United Kingdom. Participants: 417 people aged 18 or over, who had a diagnosis of schizophrenia and provided written informed consent to take part in the study. Interventions: Participants, stratified by site, were randomised to 12 months of weekly group art therapy plus standard care alone. Art therapy and activity groups had up to eight members and lasted for 90 minutes. In art therapy, members were given access to a range of art materials and encouraged to use these to express themselves freely. Members of activity groups were offered various activities that did not involve use of art or craft materials and were encouraged to collectively select those they wanted to pursue. Main outcome measures: The primary outcomes were global functioning, measured using the global assessment of functioning scale, and mental health systems, measured using the positive and negative syndrome scale, 24 months after randomisation. Main secondary outcomes were levels of group attendance, social functioning, and satisfaction with care at 12 and 24 months. Results: 24 participants were assigned to either art therapy (n=140), activity groups (n=140), or standard care alone (n=137). Primary outcomes between the three study arms did not differ. The adjusted mean difference between art therapy and standard care at 24 months on the global assessment of functioning scale was -0.9 (95% confidence interval -3.8 to 2.1), and on the positive and negative syndrome scale was 0.7 (-3.1 to 4.6). Secondary outcomes did not differ between those referred to art therapy or those referred to standard care at 12 or 24 months. Conclusions: Referring people with established schizophrenia to group art therapy as delivered in this trial did not improve global functioning, metnal health, or other health related outcomes. Trial registration: Current Controlled Trials ISRCTN46150447.
Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalBritish Medical Journal
DOIs
Publication statusPublished - 28 Feb 2012

Fingerprint

Pragmatic Clinical Trials
Art Therapy
Group Psychotherapy
Schizophrenia
Therapeutics
Art
Secondary Care
Health
Random Allocation
Informed Consent
Mental Health
Randomized Controlled Trials
Outcome Assessment (Health Care)
Confidence Intervals

Bibliographical note

© 2012 BMJ Publishing Group Ltd

Cite this

Crawford, M. J., Killaspy, H., Waller, D., Barnes, T. R. E., Barrett, B., Byford, S., ... Tyrer, P. (2012). Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial. British Medical Journal, 1-9. https://doi.org/10.1136/bmj.e846
Crawford, Mike J. ; Killaspy, Helen ; Waller, Diane ; Barnes, Thomas R.E. ; Barrett, Barbara ; Byford, Sarah ; Clayton, Katie ; Dinsmore, John ; Floyd, Siobhan ; Hoadley, Angela ; Johnson, Tony ; Kalaitzaki, Eleftheria ; King, Michael ; Leurent, Baptiste ; Maratos, Anna ; O'Neill, Francis A. ; Osborn, David P. ; Patterson, Sue ; Soteriou, Tony ; Tyrer, Peter. / Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial. In: British Medical Journal. 2012 ; pp. 1-9.
@article{5c78f56965c147a1a6e08e423bc1c2b9,
title = "Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial",
abstract = "Abstract: Objectives: To evaluate he clinical effectiveness of group art therapy for people with schizophrenia and to test whether any benefits exceed those of an active control treatment. Design: Three arm, rater blinded, pragmatic, randomised controlled trial. Setting: Secondary care services across 15 sites in the United Kingdom. Participants: 417 people aged 18 or over, who had a diagnosis of schizophrenia and provided written informed consent to take part in the study. Interventions: Participants, stratified by site, were randomised to 12 months of weekly group art therapy plus standard care alone. Art therapy and activity groups had up to eight members and lasted for 90 minutes. In art therapy, members were given access to a range of art materials and encouraged to use these to express themselves freely. Members of activity groups were offered various activities that did not involve use of art or craft materials and were encouraged to collectively select those they wanted to pursue. Main outcome measures: The primary outcomes were global functioning, measured using the global assessment of functioning scale, and mental health systems, measured using the positive and negative syndrome scale, 24 months after randomisation. Main secondary outcomes were levels of group attendance, social functioning, and satisfaction with care at 12 and 24 months. Results: 24 participants were assigned to either art therapy (n=140), activity groups (n=140), or standard care alone (n=137). Primary outcomes between the three study arms did not differ. The adjusted mean difference between art therapy and standard care at 24 months on the global assessment of functioning scale was -0.9 (95{\%} confidence interval -3.8 to 2.1), and on the positive and negative syndrome scale was 0.7 (-3.1 to 4.6). Secondary outcomes did not differ between those referred to art therapy or those referred to standard care at 12 or 24 months. Conclusions: Referring people with established schizophrenia to group art therapy as delivered in this trial did not improve global functioning, metnal health, or other health related outcomes. Trial registration: Current Controlled Trials ISRCTN46150447.",
author = "Crawford, {Mike J.} and Helen Killaspy and Diane Waller and Barnes, {Thomas R.E.} and Barbara Barrett and Sarah Byford and Katie Clayton and John Dinsmore and Siobhan Floyd and Angela Hoadley and Tony Johnson and Eleftheria Kalaitzaki and Michael King and Baptiste Leurent and Anna Maratos and O'Neill, {Francis A.} and Osborn, {David P.} and Sue Patterson and Tony Soteriou and Peter Tyrer",
note = "{\circledC} 2012 BMJ Publishing Group Ltd",
year = "2012",
month = "2",
day = "28",
doi = "10.1136/bmj.e846",
language = "English",
pages = "1--9",
journal = "British Medical Journal",
issn = "0007-1447",

}

Crawford, MJ, Killaspy, H, Waller, D, Barnes, TRE, Barrett, B, Byford, S, Clayton, K, Dinsmore, J, Floyd, S, Hoadley, A, Johnson, T, Kalaitzaki, E, King, M, Leurent, B, Maratos, A, O'Neill, FA, Osborn, DP, Patterson, S, Soteriou, T & Tyrer, P 2012, 'Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial', British Medical Journal, pp. 1-9. https://doi.org/10.1136/bmj.e846

Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial. / Crawford, Mike J.; Killaspy, Helen; Waller, Diane; Barnes, Thomas R.E.; Barrett, Barbara; Byford, Sarah; Clayton, Katie; Dinsmore, John; Floyd, Siobhan; Hoadley, Angela; Johnson, Tony; Kalaitzaki, Eleftheria; King, Michael; Leurent, Baptiste; Maratos, Anna; O'Neill, Francis A.; Osborn, David P.; Patterson, Sue; Soteriou, Tony; Tyrer, Peter.

In: British Medical Journal, 28.02.2012, p. 1-9.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial

AU - Crawford, Mike J.

AU - Killaspy, Helen

AU - Waller, Diane

AU - Barnes, Thomas R.E.

AU - Barrett, Barbara

AU - Byford, Sarah

AU - Clayton, Katie

AU - Dinsmore, John

AU - Floyd, Siobhan

AU - Hoadley, Angela

AU - Johnson, Tony

AU - Kalaitzaki, Eleftheria

AU - King, Michael

AU - Leurent, Baptiste

AU - Maratos, Anna

AU - O'Neill, Francis A.

AU - Osborn, David P.

AU - Patterson, Sue

AU - Soteriou, Tony

AU - Tyrer, Peter

N1 - © 2012 BMJ Publishing Group Ltd

PY - 2012/2/28

Y1 - 2012/2/28

N2 - Abstract: Objectives: To evaluate he clinical effectiveness of group art therapy for people with schizophrenia and to test whether any benefits exceed those of an active control treatment. Design: Three arm, rater blinded, pragmatic, randomised controlled trial. Setting: Secondary care services across 15 sites in the United Kingdom. Participants: 417 people aged 18 or over, who had a diagnosis of schizophrenia and provided written informed consent to take part in the study. Interventions: Participants, stratified by site, were randomised to 12 months of weekly group art therapy plus standard care alone. Art therapy and activity groups had up to eight members and lasted for 90 minutes. In art therapy, members were given access to a range of art materials and encouraged to use these to express themselves freely. Members of activity groups were offered various activities that did not involve use of art or craft materials and were encouraged to collectively select those they wanted to pursue. Main outcome measures: The primary outcomes were global functioning, measured using the global assessment of functioning scale, and mental health systems, measured using the positive and negative syndrome scale, 24 months after randomisation. Main secondary outcomes were levels of group attendance, social functioning, and satisfaction with care at 12 and 24 months. Results: 24 participants were assigned to either art therapy (n=140), activity groups (n=140), or standard care alone (n=137). Primary outcomes between the three study arms did not differ. The adjusted mean difference between art therapy and standard care at 24 months on the global assessment of functioning scale was -0.9 (95% confidence interval -3.8 to 2.1), and on the positive and negative syndrome scale was 0.7 (-3.1 to 4.6). Secondary outcomes did not differ between those referred to art therapy or those referred to standard care at 12 or 24 months. Conclusions: Referring people with established schizophrenia to group art therapy as delivered in this trial did not improve global functioning, metnal health, or other health related outcomes. Trial registration: Current Controlled Trials ISRCTN46150447.

AB - Abstract: Objectives: To evaluate he clinical effectiveness of group art therapy for people with schizophrenia and to test whether any benefits exceed those of an active control treatment. Design: Three arm, rater blinded, pragmatic, randomised controlled trial. Setting: Secondary care services across 15 sites in the United Kingdom. Participants: 417 people aged 18 or over, who had a diagnosis of schizophrenia and provided written informed consent to take part in the study. Interventions: Participants, stratified by site, were randomised to 12 months of weekly group art therapy plus standard care alone. Art therapy and activity groups had up to eight members and lasted for 90 minutes. In art therapy, members were given access to a range of art materials and encouraged to use these to express themselves freely. Members of activity groups were offered various activities that did not involve use of art or craft materials and were encouraged to collectively select those they wanted to pursue. Main outcome measures: The primary outcomes were global functioning, measured using the global assessment of functioning scale, and mental health systems, measured using the positive and negative syndrome scale, 24 months after randomisation. Main secondary outcomes were levels of group attendance, social functioning, and satisfaction with care at 12 and 24 months. Results: 24 participants were assigned to either art therapy (n=140), activity groups (n=140), or standard care alone (n=137). Primary outcomes between the three study arms did not differ. The adjusted mean difference between art therapy and standard care at 24 months on the global assessment of functioning scale was -0.9 (95% confidence interval -3.8 to 2.1), and on the positive and negative syndrome scale was 0.7 (-3.1 to 4.6). Secondary outcomes did not differ between those referred to art therapy or those referred to standard care at 12 or 24 months. Conclusions: Referring people with established schizophrenia to group art therapy as delivered in this trial did not improve global functioning, metnal health, or other health related outcomes. Trial registration: Current Controlled Trials ISRCTN46150447.

U2 - 10.1136/bmj.e846

DO - 10.1136/bmj.e846

M3 - Article

SP - 1

EP - 9

JO - British Medical Journal

JF - British Medical Journal

SN - 0007-1447

ER -